IDT Biologika is a full-service contract development and manufacturing organization (CDMO) offering a range of services for viral vaccines, cell and gene therapeutics, and other biologics. The company provides support from process development to clinical trial materials and commercial manufacturing, demonstrating expertise in areas such as aseptic liquid filling, lyophilization, labeling, packaging, and storage. With a focus on quality control and analytical services, IDT Biologika is equipped to handle large-scale production, adhering to FDA, EMA, and ANVISA standards. The company's integrated biopharmaceutical facilities in Germany and North American facility in Maryland cater to various developmental stages and operational requirements. Overall, IDT Biologika serves as a capable partner for biopharmaceutical production and has established a strong presence in both European and North American markets.
There is no investment information
No recent news or press coverage available for IDT Biologika.